Star Metro - Lumen Technologies Accelerates Cloud-First Strategy with Amdocs, Expands Migration of Enterprise Billing Platform to Microsoft Azure

JERSEY CITY, NJ / ACCESS Newswire / May 13, 2026 / Amdocs (NASDAQ:DOX), a leading provider of software and services for communications and digital service providers, today announced that Lumen Technologies is accelerating its cloud-first strategy with Amdocs, expanding the migration of mission-critical platforms to the public cloud with the migration of one of its enterprise billing platforms to Microsoft Azure.

This engagement builds on the ongoing collaboration between Lumen and Amdocs and represents a continued step in Lumen's strategy to transition mission-critical enterprise platforms to the public cloud. The initiative supports Lumen's cloud-first strategy by using Microsoft Azure to enhance resilience, improve operational agility, and enable greater scalability, while maintaining the reliability required for customer-critical workloads.

Lumen's billing platform plays a central role in supporting its enterprise revenue operations, making this migration a key milestone in evolving Lumen's enterprise platform landscape to support growing demand and innovation.

As part of the engagement, Amdocs will apply its agentic, AI-enabled migration capabilities through Amdocs Operating System framework (aOS) to accelerate complex cloud journeys, reduce transformation risk, and embed continuous optimization from day one.

"Enterprise billing is a foundational capability for how we serve our business customers. By working with Amdocs to migrate one of our billing platforms to Microsoft Azure, we are strengthening resiliency and scalability while improving operational efficiency," said Chad Naeger, Chief Information Officer at Lumen.

"As Lumen advances its multi-cloud transformation, partners like Amdocs play a critical role in helping us migrate and modernize mission-critical applications and platforms across Microsoft Azure, Google Cloud, and AWS," said Sulabh Sood, Vice President of Cloud Transformation at Lumen.

"We are proud to continue supporting Lumen in advancing its cloud strategy by migrating its mission-critical enterprise billing platform to Microsoft Azure," said Anthony Goonetilleke, Group President of Technology and Head of Strategy at Amdocs. "This engagement reflects Amdocs' role as a long-term partner in operating and evolving core consumer and business platforms, ensuring reliability while enabling scalable growth in the cloud."

Supporting Resources

• Keep up with Amdocs news by visiting the company's website

• Follow us on X, Facebook, LinkedIn, and YouTube

About Amdocs

Amdocs helps the world's leading communications and media companies deliver exceptional customer experiences through reliable, efficient, and secure operations at scale. We provide software products and services that embed intelligence into how work runs across business, IT, and network domains - delivering measurable outcomes in customer experience, network performance, cloud modernization, and revenue growth. With our talented people, and more than 40 years of experience running mission-critical systems around the globe, Amdocs runs billions of transactions daily. Our technology is relied on every day, connecting people worldwide and advancing a more inclusive, connected world. Together, we help those who shape the future to make it amazing. Amdocs is listed on the NASDAQ Global Select Market (NASDAQ: DOX) and reported revenue of $4.53 billion in fiscal 2025. For more information, visit www.amdocs.com.

Amdocs' Forward-Looking Statement

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events or pandemics, changes to trade policies including tariffs and trade restrictions, as well as the current inflationary environment, and the effects of these conditions on the Company's customers' businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company's customers. Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company's offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2025, filed on December 15, 2025, and for the first quarter of fiscal 2026 on February 17, 2026.

Media Contacts

Mario Hajiloizi
Amdocs Public Relations
E-mail: [email protected]

SOURCE: Amdocs Management Limited

View the original press release on ACCESS Newswire

S.Belanger--SMC